Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received October 22, 2016
- Accepted after revision March 3, 2017
- Published online July 12, 2017.
Article Versions
- Latest version (May 11, 2017 - 08:42).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2017 by American Journal of Neuroradiology Indicates open access to non-subscribers at www.ajnr.org
Author Information
- Y. Forslina,b,
- S. Shamsa,b,
- F. Hashima,b,
- P. Aspelina,b,
- G. Bergendala,b,c,
- J. Martolaa,b,
- S. Fredriksonc,d,
- M. Kristoffersen-Wiberga,b and
- T. Granberga,b
- aFrom the Departments of Clinical Science Intervention and Technology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
- bRadiology (Y.F., S.S., F.H., P.A., G.B., J.M., M.K.-W., T.G.)
- cNeurology (G.B., S.F.)
- dClinical Neuroscience (S.F.), Karolinska Institutet, Stockholm, Sweden.
- Please address correspondence to Yngve Forslin, MD, Department of Clinical Science, Intervention and Technology, C1-46, Karolinska University Hospital, 141 86 Stockholm, Sweden; e-mail: yngve.forslin{at}ki.se
Altmetrics
Cited By...
Jump to section
Related Articles
Cited By...
- MR Imaging Signs of Gadolinium Retention Are Not Associated with Long-Term Motor and Cognitive Outcomes in Multiple Sclerosis
- Does Gadolinium Deposition Lead to Metabolite Alteration in the Dentate Nucleus? An MRS Study in Patients with MS
- Safety of Gadolinium-Based Contrast Agents in Patients with Stage 4 and 5 Chronic Kidney Disease: a Radiologists Perspective
- Cumulative gadodiamide administration leads to brain gadolinium deposition in early MS
- Signal Hyperintensity on Unenhanced T1-Weighted Brain and Cervical Spinal Cord MR Images after Multiple Doses of Linear Gadolinium-Based Contrast Agent
- Gadolinium Retention in the Brain: An MRI Relaxometry Study of Linear and Macrocyclic Gadolinium-Based Contrast Agents in Multiple Sclerosis